Compare Viatris Inc (VTRS) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viatris Inc vs Financial Select Sector SPDR Fund — how do they compare? Viatris Inc trades at $17.64 (market cap $20.03B), while Financial Select Sector SPDR Fund trades at $54.73 (market cap $50.06B). The key difference: Financial Select Sector SPDR Fund is far larger — about 2.5× Viatris Inc's market cap, and Viatris Inc pays a 2.75% dividend while Financial Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Viatris Inc for 57 Days and Financial Select Sector SPDR Fund for 104 Days on average.
| VTRS | XLF | |
|---|---|---|
Market Cap | $20.03B | $50.06B |
Volume | 14,109,977 | 47,464,120 |
Sector | Health | — |
52-Week High | $18.27 | $58.55 |
52-Week Low | $9.74 | $47.80 |
Typical Hold Time | 57 Days | 104 Days |
Enterprise Value | $32.15B | — |
Dividend Yield | 2.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Viatris (VTRS) trades at $17.44, down 0.29% on the day, with a bullish technical signal from moving averages and oversold short-term RSI. The company reported three consecutive quarterly earnings beats in 2026, with Q2 EPS of $0.69 beating estimates by 14.8%. Revenue for 2025 was $14.3B, though net income was negative $3.51B, reflecting margin pressure. Positive news includes a new drug approval in Japan and recognition as a top employer.
The outlook is mixed: strong cash flow generation and deleveraging support shareholder returns via dividends and buybacks, but profitability challenges and high debt levels pose risks. Analyst consensus is a 'Buy' with a $22.17 price target, implying 27% upside. Investment appeal hinges on execution of pipeline growth and margin improvement amid competitive and pricing pressures in the generics market.
XLF trades at $54.73, up 1.82% with a bearish technical signal as moving averages and ADX indicators suggest selling pressure. The financial ETF faces sector headwinds with bank stocks lagging the S&P 500 by the widest margin since 1990 despite rising profits. Recent Fed stress test changes and interest rate hikes create both opportunities and challenges for financial sector performance.
Financial sector exposure benefits from rising interest rates but faces regulatory uncertainty and market underperformance risks. The ETF's concentrated 76-holding portfolio offers targeted financial exposure while competing with broader alternatives. Sector rotation into financials by fund managers in Q2 2026 suggests institutional confidence despite recent relative weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
